Most people who smoke want to quit, and for good reason. Reliable estimates say that smoking-related illnesses kill more than 5 million people around the world each year.
At the time of its approval in 2006, Chantix (marketed outside the U.S. as Champix) was the first prescription smoking cessation medicine to be approved in 10 years. A non-nicotine-based pharmaceutical, Chantix is proven more effective in helping smokers quit than its leading competitor in the prescription-only market.
In the U.S., Pfizer offers the GETQUIT Plan for free with a Chantix prescription. This tailored, 52-week, Web- and phone-based behavior modification program helps patients prepare for a life without cigarettes. It provides ongoing support with a hotline staffed with Mayo Clinic-trained Quit Coaches and daily support during the first 12 weeks to help smokers learn how to trade old smoking routines for new and healthier habits.
